|
|
|
|
| Advertisement |
 |
|
|
|
|
| Special Feature |
 |
|
Pharm Exec's Emerging Pharma Leaders 2016 |
Pharm Exec's 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable—or complacent.
/Read more/ |
|
|
|
| Industry update |
| //Verona Pharma (Cardiff, UK) announced the appointment of Vikas Sinha to the Board of Verona Pharma as a Non-Executive Director, with immediate effect.//VAXIMM (Basel, Switzerland and Mannheim, Germany)announced the appointment of Matthias Schroff, PhD, as Chief Executive Officer (CEO).//GNA Biosolutions (Martinsried, Germany) appointed Frank Krieg-Schneider as Managing Director and CEO.//TxCell SA (Valbonne, France) appointed Olivier Danos, PhD, Senior Vice President of Cell and Gene Therapy at Biogen, to its Scientific Advisory Board.// |
|
|
| |
|
|
